{"id":"https://openalex.org/W1847190482","doi":"https://doi.org/10.1177/1076029615585991","title":"Real-World Medical Cost Avoidance When New Oral Anticoagulants are Used Versus Warfarin for Venous Thromboembolism in the United States","display_name":"Real-World Medical Cost Avoidance When New Oral Anticoagulants are Used Versus Warfarin for Venous Thromboembolism in the United States","alternate_titles":[],"publication_year":2015,"publication_date":"2015-05-19","ids":{"openalex":"https://openalex.org/W1847190482","doi":"https://doi.org/10.1177/1076029615585991","mag":"1847190482","pmid":"https://pubmed.ncbi.nlm.nih.gov/25993994"},"language":"en","primary_location":{"id":"doi:10.1177/1076029615585991","doi":"https://doi.org/10.1177/1076029615585991","is_oa":false,"landing_page_url":"https://doi.org/10.1177/1076029615585991","pdf_url":null,"source":{"id":"https://openalex.org/S8942861","display_name":"Clinical and Applied Thrombosis/Hemostasis","issn_l":"1076-0296","issn":["1076-0296","1938-2723"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-70","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320017","host_organization_name":"SAGE Publishing","host_organization_lineage":["https://openalex.org/P4310320017"],"host_organization_lineage_names":["SAGE Publishing"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical and Applied Thrombosis/Hemostasis","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W1847190482"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5019794460","display_name":"Alpesh Amin","orcid":"https://orcid.org/0000-0002-9790-0245","observed_orcids":["https://orcid.org/0000-0002-9790-0245"]},"institutions":[{"id":"https://openalex.org/I204250578","display_name":"University of California, Irvine","ror":"https://ror.org/04gyf1771","country_code":"US","type":"education","lineage":["https://openalex.org/I204250578"]}],"countries":["US"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Alpesh Amin","raw_affiliation_strings":["Department of Medicine, Hospitalist Program, School of Medicine, University of California, Irvine, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medicine, Hospitalist Program, School of Medicine, University of California, Irvine, CA, USA","institution_ids":["https://openalex.org/I204250578"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5065216782","display_name":"Amanda S. Bruno","orcid":"https://orcid.org/0009-0006-3525-079X","observed_orcids":["https://orcid.org/0009-0006-3525-079X"]},"institutions":[{"id":"https://openalex.org/I4210091812","display_name":"Bristol-Myers Squibb (United States)","ror":"https://ror.org/00gtmwv55","country_code":"US","type":"company","lineage":["https://openalex.org/I4210091812"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Amanda Bruno","raw_affiliation_strings":["Bristol-Myers Squibb, CV Health Economics & Outcomes Research, Plainsboro, NJ, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Bristol-Myers Squibb, CV Health Economics & Outcomes Research, Plainsboro, NJ, USA","institution_ids":["https://openalex.org/I4210091812"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5050220227","display_name":"Jeffrey N. Trocio","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Jeffrey Trocio","raw_affiliation_strings":["Pfizer, Inc, Global Value & Health - Outcomes & Evidence, New York, NY, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pfizer, Inc, Global Value & Health - Outcomes & Evidence, New York, NY, USA","institution_ids":["https://openalex.org/I180857899"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5080303082","display_name":"Jay Lin","orcid":"https://orcid.org/0000-0002-6376-8469","observed_orcids":["https://orcid.org/0000-0002-6376-8469"]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Jay Lin","raw_affiliation_strings":["Novosys Health, Health Economics & Outcomes Research, Green Brook, NJ, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Novosys Health, Health Economics & Outcomes Research, Green Brook, NJ, USA","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5026378192","display_name":"Melissa Lingohr-Smith","orcid":"https://orcid.org/0000-0002-3046-9278","observed_orcids":["https://orcid.org/0000-0002-3046-9278"]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Melissa Lingohr-Smith","raw_affiliation_strings":["Novosys Health, Health Economics & Outcomes Research, Green Brook, NJ, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Novosys Health, Health Economics & Outcomes Research, Green Brook, NJ, USA","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":["https://openalex.org/A5019794460"],"corresponding_institution_ids":["https://openalex.org/I204250578"],"apc_list":{"value":2650,"currency":"USD","value_usd":2650},"apc_paid":null,"fwci":4.8658,"has_fulltext":false,"cited_by_count":25,"citation_normalized_percentile":{"value":0.94902844,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":92,"max":97},"biblio":{"volume":"22","issue":"1","first_page":"5","last_page":"11"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10285","display_name":"Venous Thromboembolism Diagnosis and Management","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2724","display_name":"Internal Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10285","display_name":"Venous Thromboembolism Diagnosis and Management","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2724","display_name":"Internal Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10804","display_name":"Health Systems, Economic Evaluations, Quality of Life","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T10065","display_name":"Atrial Fibrillation Management and Outcomes","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/direct-oral-anticoagulants","display_name":"direct oral anticoagulants","score":0.9980000257492065},{"id":"https://openalex.org/keywords/warfarin","display_name":"warfarin","score":0.9919999837875366},{"id":"https://openalex.org/keywords/venous-thromboembolism","display_name":"venous thromboembolism","score":0.9990000128746033},{"id":"https://openalex.org/keywords/apixaban","display_name":"apixaban","score":0.8579999804496765},{"id":"https://openalex.org/keywords/rivaroxaban","display_name":"rivaroxaban","score":0.9980000257492065},{"id":"https://openalex.org/keywords/edoxaban","display_name":"edoxaban","score":0.9959999918937683},{"id":"https://openalex.org/keywords/dabigatran","display_name":"dabigatran","score":1.0},{"id":"https://openalex.org/keywords/major-bleeding","display_name":"major bleeding","score":0.7139999866485596},{"id":"https://openalex.org/keywords/recurrent-venous-thromboembolism","display_name":"recurrent venous thromboembolism","score":0.9570000171661377},{"id":"https://openalex.org/keywords/payer-perspective","display_name":"payer perspective","score":0.5730000138282776}],"concepts":[{"id":"https://openalex.org/C2778661090","wikidata":"https://www.wikidata.org/wiki/Q420262","display_name":"Rivaroxaban","level":4,"score":0.8911362886428833},{"id":"https://openalex.org/C2780638905","wikidata":"https://www.wikidata.org/wiki/Q414462","display_name":"Apixaban","level":5,"score":0.8789688348770142},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8574522733688354},{"id":"https://openalex.org/C2776301958","wikidata":"https://www.wikidata.org/wiki/Q407431","display_name":"Warfarin","level":3,"score":0.8289982080459595},{"id":"https://openalex.org/C2778810321","wikidata":"https://www.wikidata.org/wiki/Q419345","display_name":"Dabigatran","level":4,"score":0.6979783773422241},{"id":"https://openalex.org/C2780290652","wikidata":"https://www.wikidata.org/wiki/Q21011234","display_name":"Edoxaban","level":5,"score":0.6730210781097412},{"id":"https://openalex.org/C2991741193","wikidata":"https://www.wikidata.org/wiki/Q2751330","display_name":"Venous thromboembolism","level":3,"score":0.6334038376808167},{"id":"https://openalex.org/C177713679","wikidata":"https://www.wikidata.org/wiki/Q679690","display_name":"Intensive care medicine","level":1,"score":0.43380483984947205},{"id":"https://openalex.org/C194828623","wikidata":"https://www.wikidata.org/wiki/Q2861470","display_name":"Emergency medicine","level":1,"score":0.4241124093532562},{"id":"https://openalex.org/C2908647359","wikidata":"https://www.wikidata.org/wiki/Q2625603","display_name":"Population","level":2,"score":0.4104209542274475},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.23819544911384583},{"id":"https://openalex.org/C2779161974","wikidata":"https://www.wikidata.org/wiki/Q815819","display_name":"Atrial fibrillation","level":2,"score":0.1649354100227356},{"id":"https://openalex.org/C2780868729","wikidata":"https://www.wikidata.org/wiki/Q261327","display_name":"Thrombosis","level":2,"score":0.1330265998840332},{"id":"https://openalex.org/C99454951","wikidata":"https://www.wikidata.org/wiki/Q932068","display_name":"Environmental health","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000284","descriptor_name":"Administration, Oral","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000925","descriptor_name":"Anticoagulants","qualifier_ui":"Q000191","qualifier_name":"economics","is_major_topic":true},{"descriptor_ui":"D000925","descriptor_name":"Anticoagulants","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D003365","descriptor_name":"Costs and Cost Analysis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009010","descriptor_name":"Monte Carlo Method","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014481","descriptor_name":"United States","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014859","descriptor_name":"Warfarin","qualifier_ui":"Q000191","qualifier_name":"economics","is_major_topic":true},{"descriptor_ui":"D014859","descriptor_name":"Warfarin","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D054556","descriptor_name":"Venous Thromboembolism","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D054556","descriptor_name":"Venous Thromboembolism","qualifier_ui":"Q000191","qualifier_name":"economics","is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.1177/1076029615585991","doi":"https://doi.org/10.1177/1076029615585991","is_oa":false,"landing_page_url":"https://doi.org/10.1177/1076029615585991","pdf_url":null,"source":{"id":"https://openalex.org/S8942861","display_name":"Clinical and Applied Thrombosis/Hemostasis","issn_l":"1076-0296","issn":["1076-0296","1938-2723"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-70","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320017","host_organization_name":"SAGE Publishing","host_organization_lineage":["https://openalex.org/P4310320017"],"host_organization_lineage_names":["SAGE Publishing"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical and Applied Thrombosis/Hemostasis","raw_type":"journal-article"},{"id":"pmid:25993994","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/25993994","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis","raw_type":"Comparative Study"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.98580002784729,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":17,"referenced_works":["https://openalex.org/W1978745101","https://openalex.org/W1978768262","https://openalex.org/W1992868987","https://openalex.org/W2012519169","https://openalex.org/W2072636991","https://openalex.org/W2081139146","https://openalex.org/W2100283122","https://openalex.org/W2115787552","https://openalex.org/W2117662968","https://openalex.org/W2118092611","https://openalex.org/W2130199362","https://openalex.org/W2131099415","https://openalex.org/W2134430286","https://openalex.org/W2160625453","https://openalex.org/W2166402206","https://openalex.org/W2169493096","https://openalex.org/W2954950630"],"related_works":["https://openalex.org/W1418588286","https://openalex.org/W2051807448","https://openalex.org/W1992868987","https://openalex.org/W2160161999","https://openalex.org/W2623634265","https://openalex.org/W2166758799","https://openalex.org/W2313837435","https://openalex.org/W2345113747","https://openalex.org/W2126190086","https://openalex.org/W1544643443"],"abstract_inverted_index":{"OBJECTIVE:":[0],"Real-world":[1],"medical":[2,60,84,110,143,175,187],"cost":[3,111,144,188],"avoidances":[4,112,145],"from":[5,48,68,75],"a":[6,69],"US":[7,70],"payer":[8,71],"perspective":[9,72],"were":[10,42,73,93,102,115],"estimated":[11],"when":[12,156],"new":[13],"oral":[14],"anticoagulants":[15],"(NOACs)":[16],"are":[17,162,177],"used":[18,163],"instead":[19,164],"of":[20,25,37,158,165,169],"warfarin":[21,52,92,114,166],"for":[22,86,117,167],"the":[23,49,55,76,159,180,184],"treatment":[24,168],"patients":[26,63,87,119,170],"with":[27,64,89,121,131,171,195],"venous":[28],"thromboembolism":[29],"(VTE).":[30],"METHODS:":[31],"Reductions":[32],"in":[33,82,198],"real-world":[34,154,186],"event":[35,203],"rates":[36],"recurrent":[38],"VTE":[39,65,118,200],"and":[40,66,97,138,201],"MB":[41,67,202],"obtained":[43,74],"by":[44,128],"applying":[45],"rate":[46],"reductions":[47,197],"NOACs":[50,90,161],"versus":[51,91,113],"trials":[53],"to":[54],"Worcester":[56],"population.":[57],"Incremental":[58],"annual":[59,108,174],"costs":[61,85,176],"among":[62],"literature":[77],"or":[78],"claims":[79],"databases.":[80],"Differences":[81],"total":[83,109],"treated":[88,120,130],"then":[94],"estimated.":[95],"Univariate":[96],"Monte":[98],"Carlo":[99],"sensitivity":[100,149],"analyses":[101],"additionally":[103],"carried":[104],"out.":[105],"RESULTS:":[106],"The":[107,142],"greatest":[116,185],"apixaban":[122,182],"(-US$4440":[123],"per":[124],"patient-year":[125],"[ppy]),":[126],"followed":[127],"those":[129],"rivaroxaban":[132],"(-US$2971":[133],"ppy),":[134,137],"edoxaban":[135],"(-US$1957":[136],"dabigatran":[139],"(-US$572":[140],"ppy).":[141],"remained":[146],"consistent":[147],"under":[148],"analyses.":[150],"CONCLUSION:":[151],"Based":[152],"on":[153],"data,":[155],"any":[157],"evaluated":[160],"acute":[172],"VTE,":[173],"reduced.":[178],"Of":[179],"NOACs,":[181],"has":[183],"avoidance,":[189],"as":[190],"its":[191],"use":[192],"is":[193],"associated":[194],"substantial":[196],"both":[199],"rates.":[204]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W1847190482","counts_by_year":[{"year":2025,"cited_by_count":2},{"year":2023,"cited_by_count":2},{"year":2021,"cited_by_count":2},{"year":2020,"cited_by_count":4},{"year":2019,"cited_by_count":2},{"year":2018,"cited_by_count":4},{"year":2017,"cited_by_count":3},{"year":2016,"cited_by_count":4},{"year":2015,"cited_by_count":2}],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2016-06-24T00:00:00"}
